Results 211 to 220 of about 88,842 (261)

Agents acting on central dopamine receptors

1977
Dopamine was long believed to be only of functional significance as a precursor of epinephrine and norepinephrine. It became a focus of interest only after Carlsson’s [1] demonstration of its presence in relatively high concentrations in various parts of the brain, mainly striatum [2] and inner retina [3].
N, Kumar, P C, Jain
openaire   +2 more sources

Chapter 2 Antipsychotic Agents and Dopamine Agonists

1978
Publisher Summary This chapter summarizes the effective results of neuroleptic (antipsychotic) drugs in symptomatic treatment of schizophrenia, whose etiologies are unknown and may not be identical. This review begins with the recent discoveries about dopamine (DA) receptors.
John McDermed, Richard J. Miller
openaire   +1 more source

A role for dopamine in feeding responses produced by orexigenic agents

Brain Research, 2004
Dopamine-deficient (DD) mice become hypophagic and die of starvation by 3 to 4 weeks of age unless dopamine is restored by daily treatment with l-3-4-dihydroxyphenylalanine (l-dopa). We demonstrate here that DD mice mount qualitatively normal counter-regulatory blood glucose responses to insulin and 2-deoxy-d-glucose (2-DG).
Thomas S, Hnasko, Mark S, Szczypka, William A, Alaynick, Matthew J, During, Richard D, Palmiter   +4 more
openaire   +2 more sources

The Role of Dopaminergic Agents and the Dopamine Receptor in Treatment for CHF

The Journal of Clinical Pharmacology, 1989
Cet article etudie l'opportunite de l'utilisation des substances dopaminergiques dans le traitement de l'insuffisance cardiaque congestive comme alternative au traitement par digitaliques et diuretiques. Les proprietes cardiovasculaires de la dopamine, la propylbutyldopamine, le levodopa et la dobutamine sont connues et ces substances presentent ...
R A, Carey, L, Jacob
openaire   +2 more sources

ENDOCRINE EFFECTS OF DOMPERIDONE: A PERIPHERAL DOPAMINE BLOCKING AGENT

Clinical Endocrinology, 1981
SUMMARYIn the present study, effects of domperidone, a peripheral dopamine blocking agent, on prolactin and growth hormone were examined to determine whether dopamine regulation of these hormones involved structures external to the blood‐brain barrier. A clearcut elevation in prolactin was produced by domperidone.
G M, Brown, H, Verhaegan, T B, Van Wimersma Greidanus, J, Brugmans   +3 more
openaire   +2 more sources

Effects of olanzapine and lithium carbonate antipsychotic agents on dopamine oxidation

The Analyst, 2023
Effects of olanzapine and lithium carbonate on dopamine oxidation.
Kaikai Han, Jingjie Cui, Shaowei Chen, Tao Yu   +3 more
openaire   +2 more sources

Inhibition of dopamine β-hydroxylase by bidentate chelating agents

Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
1-2H-Phthalazine hydrazone (hydralazine; HYD), 2-1H-pyridinone hydrazone (2-hydrazinopyridine; HP), 2-quinoline-carboxylic acid (QCA), 1-isoquinolinecarboxylic acid (IQCA), 2,2'-bi-1H-imidazole (2,2'-biimidazole; BI), and 1H-imidazole-4-acetic acid (imidazole-4-acetic acid; IAA) directly and reversibly inhibit homogeneous soluble bovine dopamine beta ...
S, Townes, C, Titone, R C, Rosenberg
openaire   +2 more sources

Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents

Psychopharmacology Bulletin
Dopamine receptor blocking agents (DRBAs, also known as antipsychotics) are frequently used in hospitalized patients. These medications carry a significant side effect burden and should be used judiciously. This purpose of this study is to examine patient, disease, and medication characteristics associated with the use of DRBAs in the inpatient setting
Shaina, Schwartz, Lauren, Dinkla, Jocelyn, Pullen, Rachel, Bernard, Archana, Kumar   +4 more
openaire   +2 more sources

Clinical Pharmacology of Dopamine-Modulating Agents in Tourette’s Syndrome

2013
Forty years of research and clinical practice have proved dopamine (DA) receptor antagonists to be effective agents in the treatment of Tourette's syndrome (TS), allowing a significant tic reduction of about 70%. Their main effect seems to be mediated by the blockade of the striatal DA-D2 receptors. Various typical and atypical agents are available and
Sabine, Mogwitz, Judith, Buse, Stefan, Ehrlich, Veit, Roessner   +3 more
openaire   +2 more sources

Chapter 2. Antipsychotic Agents and Dopamine Agonists

1980
Publisher Summary With respect to the DA theory of schizophrenia, arguments have recently been presented that increased dopaminergic transmission produces positive symptomatology of schizophrenia (Type I syndrome, equivalent to an acute state of the disease), while other factors, such as structural changes in the brain, produce the negative ...
David C. Remy, Gregory E. Martin
openaire   +1 more source